FDA — authorised 19 March 2014
- Marketing authorisation holder: PIRAMAL IMAGING
- Status: approved
🇺🇸 Neuraceq in United States
FDA authorised Neuraceq on 19 March 2014
Marketing authorisation
Neuraceq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Neuraceq approved in United States?
Yes. FDA authorised it on 19 March 2014.
Who is the marketing authorisation holder for Neuraceq in United States?
PIRAMAL IMAGING holds the US marketing authorisation.